TANIA MARTINEZ-BEASLEY: Open Payments
NPI 1154501740 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 8 payments from 7 companies in 2025. Trend: 2023 $328 · 2024 $280 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $108 |
| Amgen Inc. | 2 | $28 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: REZDIFFRA, OTEZLA, UBRELVY, REXULTI, Kerendia, JARDIANCE, LEQVIO.
Industry payments across NY — which companies pay providers there.
